PE15197A1 - Proteinas anti-obesidad - Google Patents
Proteinas anti-obesidadInfo
- Publication number
- PE15197A1 PE15197A1 PE1996000072A PE00007296A PE15197A1 PE 15197 A1 PE15197 A1 PE 15197A1 PE 1996000072 A PE1996000072 A PE 1996000072A PE 00007296 A PE00007296 A PE 00007296A PE 15197 A1 PE15197 A1 PE 15197A1
- Authority
- PE
- Peru
- Prior art keywords
- xaa
- gln
- asn
- glu
- leu
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE REFIERE A PROTEINAS DE FORMULA GENERAL I, DONDE: Xaa EN LAS POSICIONES 4, 7, 28, 34, 56, 62, 63, 75, 130, 134 Y 139 ES GLN O GLU 0 PUEDE ESTAR AUSENTE (SOLO EN 28); Xaa EN 54, 68 Y 136 ES MET, LEU, ENTRE OTROS; Xaa EN 22 Y 72 ES ASN, ASP O GLU; Xaa EN 78 Y 82 ES GLN, ASN O ASP; Xaa EN 27 ES THR O ALA; Xaa EN 77 ES SER O ALA; Xaa EN 118 ES GLY O LEU; Y QUE TIENE COMO MINIMO UNA SUSTITUCION EN LAS POSICIONES 97, 100, 101, 102, 103, 105, 106, 107, 108, 111, 138 Y/O EXISTEN UNIONES DISULFURO ENTRE CYS EN 96 Y CIS EN 146, PARA LOGRAR MEJORAR LA ESTABILIDAD DE LA PROTEINA. TAMBIEN SE REFIERE AL PROCESO DE HACER LAS PROTEINAS DE FORMULA GENERAL I, QUE COMPRENDE: A) TRANSFORMAR UN MINERAL CON INCLUSION DE CELULAS CON DNA, QUE CODIFICA CUALQUIERA DE LAS PROTEINAS, PROVISTAS OPCIONALMENTE DE UNA SECUENCIA GUIA OPCIONAL, QUE ES MET-R1, DONDE R1 ES UN AMINOACIDO, PREFERENTEMENTE ARG, EXCEPTO PRO; B) CULTIVAR UN MINERAL CON INCLUSION DE CELULAS Y AISLAR LA PROTEINA CODIFICADA EN (A); Y OPC. C) PARTIR ENZIMATICAMENTE LA SECUENCIA LIDER. ESTAS AGENTES TERAPEUTICOS REGULAN EL TEJIDO ADIPOSO, NORMALIZANDO EL RIESGO DE DIABETES MELLITUS TIPO II, ENFERMEDADES CARDIOVASCULARES Y EL CANCER
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38104895A | 1995-01-31 | 1995-01-31 | |
| US38363895A | 1995-02-06 | 1995-02-06 | |
| US45095P | 1995-06-22 | 1995-06-22 | |
| US216195P | 1995-08-11 | 1995-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE15197A1 true PE15197A1 (es) | 1997-05-22 |
Family
ID=27484996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1996000072A PE15197A1 (es) | 1995-01-31 | 1996-01-30 | Proteinas anti-obesidad |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPH10513451A (es) |
| KR (1) | KR19980701798A (es) |
| AR (1) | AR002956A1 (es) |
| AU (1) | AU703316B2 (es) |
| BR (1) | BR9606999A (es) |
| CA (1) | CA2211784A1 (es) |
| CO (1) | CO4480035A1 (es) |
| CZ (1) | CZ240497A3 (es) |
| FI (1) | FI973162A (es) |
| NO (1) | NO973515L (es) |
| NZ (1) | NZ301589A (es) |
| PE (1) | PE15197A1 (es) |
| PL (1) | PL321702A1 (es) |
| TR (1) | TR199600085A2 (es) |
| YU (1) | YU5296A (es) |
-
1996
- 1996-01-29 CZ CZ972404A patent/CZ240497A3/cs unknown
- 1996-01-29 CA CA002211784A patent/CA2211784A1/en not_active Abandoned
- 1996-01-29 PL PL96321702A patent/PL321702A1/xx unknown
- 1996-01-29 KR KR1019970705195A patent/KR19980701798A/ko not_active Application Discontinuation
- 1996-01-29 YU YU5296A patent/YU5296A/sh unknown
- 1996-01-29 NZ NZ301589A patent/NZ301589A/xx unknown
- 1996-01-29 BR BR9606999A patent/BR9606999A/pt not_active Application Discontinuation
- 1996-01-29 CO CO96003533A patent/CO4480035A1/es unknown
- 1996-01-29 AU AU47052/96A patent/AU703316B2/en not_active Withdrawn - After Issue
- 1996-01-29 JP JP8523612A patent/JPH10513451A/ja active Pending
- 1996-01-30 AR ARP960101202A patent/AR002956A1/es unknown
- 1996-01-30 PE PE1996000072A patent/PE15197A1/es not_active Application Discontinuation
- 1996-01-31 TR TR96/00085A patent/TR199600085A2/xx unknown
-
1997
- 1997-07-30 NO NO973515A patent/NO973515L/no not_active Application Discontinuation
- 1997-07-30 FI FI973162A patent/FI973162A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ240497A3 (cs) | 1998-01-14 |
| AU703316B2 (en) | 1999-03-25 |
| CO4480035A1 (es) | 1997-07-09 |
| KR19980701798A (ko) | 1998-06-25 |
| JPH10513451A (ja) | 1998-12-22 |
| PL321702A1 (en) | 1997-12-22 |
| NZ301589A (en) | 1999-02-25 |
| BR9606999A (pt) | 1997-10-28 |
| NO973515D0 (no) | 1997-07-30 |
| TR199600085A2 (tr) | 1996-08-21 |
| CA2211784A1 (en) | 1996-08-08 |
| AR002956A1 (es) | 1998-05-27 |
| FI973162A (fi) | 1997-09-30 |
| NO973515L (no) | 1997-09-29 |
| FI973162A0 (fi) | 1997-07-30 |
| AU4705296A (en) | 1996-08-21 |
| YU5296A (sh) | 1998-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Morton et al. | Collagen polymorphism in the normal and diseased blood vessel wall: investigation of collagens types I, III and V | |
| PE15297A1 (es) | Proteinas anti-obesidad | |
| Sage et al. | Characterization of a novel collagen chain in human placenta and its relation to AB collagen | |
| Craig et al. | An O-glycosylated neuroexcitatory Conus peptide | |
| KR960703433A (ko) | 증가된 생물학적 활성을 갖는 끝이 잘린 케라틴세포성장인자(kgf) (a truncated keratinocyte growth factor(kgf) having increased biological activity) | |
| PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
| NO872932L (no) | Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika. | |
| KR900013979A (ko) | 사람 유두종비루스형 16의 e7 단백질상의 면역원성 영역 | |
| ATE426024T1 (de) | C-c chemokin rezeptor 3: ckr-3 oder eos-l2 | |
| AR023099A1 (es) | Constructos de adn que codifican saratina y sus usos. | |
| KR920701451A (ko) | 인체혈청알부민의 n-말단 단편을 함유하는 융합 단백질 | |
| WO2007064917A3 (en) | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | |
| WO2003104270A3 (en) | GENES OF DUDULINE 2, EXPRESSION PRODUCTS, NON-HUMAN ANIMAL MODEL: USES IN HUMAN HEMATOLOGICAL DISEASES | |
| ES2161246T3 (es) | Factor transformante de crecimiento alfa h1. | |
| CO4790156A1 (es) | Polipeptidos de membrana de linfocito de mamifero y acidos nucleicos que los codifican | |
| Johns et al. | Studies on histones. 4. The histones of wheat germ | |
| PE50997A1 (es) | Producto del gen de la obesidad | |
| EA200100264A1 (ru) | Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly | |
| CN103038351A (zh) | 玻连蛋白:角质化细胞生长因子嵌合体 | |
| Dey et al. | Extensin from suspension-cultured potato cells: a hydroxyproline-rich glycoprotein, devoid of agglutinin activity | |
| Mayne et al. | The use of monoclonal antibodies to fragments of chicken type IV collagen in structural and localization studies. | |
| Koike et al. | The complete amino acid sequence of a mannose-binding lectin from" Kidachi Aloe"(Aloe arborescens Miller var. natalensis Berger) | |
| HENSCHEN | Disulfide bridges in the middle part of human fibrinogen | |
| PE15197A1 (es) | Proteinas anti-obesidad | |
| ATE233321T1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |